Other works have supported this idea since LGR5+ seems to be related to progression of different cancers, such as colon [24], papillary thyroid [25], breast [26], and ovarian cancers [27] by promoting epithelial ovarian cancer proliferation, metastasis, and epithelial–mesenchymal transition (EMT). Here, LGR5 is linked to cancer.